New drugs trail many old ones in effectiveness against disease

“New drugs trail many old ones in effectiveness against disease.” By Sharon Begley, Reuters.

Despite the more than $50 billion that U.S. pharmaceutical companies have spent every year since the mid-2000s to discover new medications, drugmakers have barely improved on old standbys developed decades ago. In the early years, drugs easily beat the placebo: They . . . → Read More: New drugs trail many old ones in effectiveness against disease

Report Faults Priorities in Studying Breast Cancer

“Report Faults Priorities in Studying Breast Cancer.” By Denise Grady, The New York Times

Too little of the money the federal government spends on breast cancer research goes toward finding environmental causes of the disease and ways to prevent it, according to a new report from a group of scientists, government officials and patient advocates . . . → Read More: Report Faults Priorities in Studying Breast Cancer